Status:

COMPLETED

Gene Expression Profiling in Skeletal Muscle of Healthy Subjects Treated With Ramipril

Lead Sponsor:

Medical University of Vienna

Conditions:

Healthy

Eligibility:

MALE

18-45 years

Phase:

PHASE4

Brief Summary

This project investigates the effect of ACE-inhibition on cellular metabolism by gene expression profiling of human muscle tissue, obtained by biopsy prior to and after ramipril intake. This should c...

Eligibility Criteria

Inclusion

  • Male
  • Healthy defined as absence of relevant disease
  • Caucasian
  • Aged 18-45 years
  • BMI: 18-28 kg/m2
  • Signed informed consent
  • Blood pressure between 110/45 and \<140/90 (twice at screening)

Exclusion

  • History of renal artery stenosis
  • angioneurotic edema
  • psoriasis
  • relevant renal diseases
  • RR at screening \< 110/45 mmHg.
  • Diabetes, history of hypertension, RR \> 140/90 at screening, cardiovascular disease
  • Known Diabetes mellitus of parents
  • HIV or Hepatitis B/C positive virology
  • Allergy or hypersensitivity against ACE-inhibitors / ramipril or to xylocain
  • Contraindications against the use of the drug according to the SmPC, history of angioedema
  • Any drug intake 3 weeks prior to first study day
  • History of excessive bleeding tendency / hemophilia
  • Presence of relevant illness within the last 3 weeks
  • Suspected non-compliance with study instructions and life-style requirements
  • Alcohol or drug abuse
  • Blood/Plasma donation within 4 weeks prior to study day
  • Previous exposure to antihypertensive drugs, ACE-inhibitors, in particular ramipril
  • Current smoking (any quantity), (at least 6 months of non-smoking required)

Key Trial Info

Start Date :

March 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2011

Estimated Enrollment :

18 Patients enrolled

Trial Details

Trial ID

NCT00657865

Start Date

March 1 2008

End Date

August 1 2011

Last Update

August 22 2011

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Medical University Vienna, Department of Clinical Pharacology

Vienna, Vienna, Austria, 1090